作者: Michael Ross
关键词:
摘要: Licensing new opportunities for the treatment of cancer has been an essential part Sterling Drugs' efforts to develop a series drugs. The decisions involved in making these selections have present;?d numerous organizational challenges. This paper describes formal methodology based on Analytic Hierarchy Process (AHP) recommending licensing candidates senior management. AHP permits evaluation multiple diverse criteria, all which affect final decision. These factors encom~assed ranee scientific. business. and strategic issues. 1mple6enting f i ~ approach fostered group involvement facilitated communication. Modifications were required this application, primarily permit prospective individual opportumties. modified applied retrospectively results validated basis.